Noticias y Actividades de ImpediMed

ImpediMed es una empresa que cotiza bajo el símbolo de cotización IPD (AU).

Ver el organigrama con sus 15 ejecutivos principales

Biografías más buscadas en ImpediMed

• Parmjot Bains, Managing Director and Chief Executive Officer
• Janelle Delaney, Non-Executive Director
• Christine Emmanuel-Donnelly, Non-Executive Chairman of the Board

Recientes movimientos de ejecutivos en ImpediMed

• Andrew Grant que es Executive Director and Vice President, Product Development and Customer Solutions, pasará a ser Non-Executive Director el 19 de nov.. de 2024  (noticia publicada el 21 de octubre de 2024).

Crear su alerta
para seguir los movimientos de los ejecutivos en ImpediMed.

ImpediMed tiene 1.020 competidores entre los que se incluyen Philips (Países Bajos), Medtronic (Irlanda) y Thermo Fisher Scientific (Estados Unidos).

Popular M&A news in Equipos médicos

• Globus Medical has announced the acquisition of Nevro  (publicado el 4 de abril de 2025).
• Amboss acaba de anunciar una recaudación de fondos de 259 millones de dólares. (publicado el 3 de abril de 2025).
• Patricia Industries has announced the acquisition of Nova Biomedical  (publicado el 24 de marzo de 2025).

Otros contactos sugeridos en el sector Equipos médicos

• Volker Wetekam - Director en Elekta Instrument
• Andrew Elbardissi - Director en Medical Microinstruments
• Marc Casper - Chairman of the Board, President and Chief Executive Officer en Thermo Fisher Scientific

Saber más sobre el sector Equipos médicos

Últimos comunicados de prensa de ImpediMed

• Newsroom | ImpediMed - Part 5
• Newsroom | ImpediMed - Part 4
• Early Detection of Lymphedema and Value of Compression Garments After Breast Cancer Treatments with Dr. Steven Chen | ImpediMed
• New Data Presented at the 2022 San Antonio Breast Cancer Symposium Shows Early Detection using L-Dex and Intervention Improves Lymphedema Progression-Free Survival
• ImpediMed Reaches Milestone of 500,000 Patient Tests Performed with the SOZO Digital Health Platform
• New Data Confirms Early Detection and Intervention of Lymphedema Improves Quality of Life for Breast Cancer Patients Who Avoid Chronic Lymphedema
• Current Data Support Early Detection and Intervention to Reduce Rates of Breast Cancer-Related Lymphedema
• ImpediMed Expands Use of SOZO in Leading Cancer Centers Focused on Reducing the Impact of Lymphedema after Breast Cancer
• ImpediMed Announces U.S. Launch of Lymphedema Prevention Program with GenesisCare a Global Organization Dedicated to Care of Cancer Patients
• ImpediMed Announces Two Posters at Heart Failure Society of America Annual Scientific Meeting That Demonstrate Utility of SOZO® Digital Health Platform for Heart Failure Patients
• View more press releases Close

Redes sociales sobre ImpediMed

• ImpediMed en Wikipedia, Google News y Yahoo Finance
• ImpediMed en LinkedIn, Twitter y YouTube